Linking this with the above discussion, obesity and insulin resistance lead to elevated aldosterone levels and MR activation which promotes arterial remodeling, and pathologically increased vascular stiffness, and predicts the risk of subsequent hypertension, CVD, and metabolic syndrome. Here, NR3C2 is linked to metabolic syndrome.